combretastatin has been researched along with 4-hydroxy-n-desmethyltamoxifen in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ana, G; Bright, SA; Fayne, D; Keely, NO; Kelly, PM; Meegan, MJ; Yassin, B; Zisterer, DM | 1 |
1 other study(ies) available for combretastatin and 4-hydroxy-n-desmethyltamoxifen
Article | Year |
---|---|
Novel Selective Estrogen Receptor Ligand Conjugates Incorporating Endoxifen-Combretastatin and Cyclofenil-Combretastatin Hybrid Scaffolds: Synthesis and Biochemical Evaluation.
Topics: Antineoplastic Agents, Phytogenic; Bibenzyls; Cell Proliferation; Crystallography, X-Ray; Cyclofenil; Drug Screening Assays, Antitumor; G2 Phase Cell Cycle Checkpoints; Humans; Inhibitory Concentration 50; Leukocytes, Mononuclear; Ligands; MCF-7 Cells; Models, Molecular; Molecular Conformation; Protein Binding; Receptors, Estrogen; Tamoxifen | 2017 |